70 related articles for article (PubMed ID: 10715796)
1. [Study on endothlin and its gene expression in splanchnic vessels in cirrhotic rats].
Yu J; Liang K; Tian D
Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):233-5. PubMed ID: 10715796
[TBL] [Abstract][Full Text] [Related]
2. Expression of somatostatin receptors in splanchnic blood vessels of normal and cirrhotic rats.
Reynaert H; van Rossen E; Uyama N; Chatterjee N; Kumar U; Urbain D; Geerts A
Liver Int; 2007 Aug; 27(6):825-31. PubMed ID: 17617126
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase in hyperdynamic portal hypertensive rats.
Cao H; Xu J; Hua R; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):252-6. PubMed ID: 16698586
[TBL] [Abstract][Full Text] [Related]
4. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
[TBL] [Abstract][Full Text] [Related]
6. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
Feng H; Leng X; Zhang Z
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
[TBL] [Abstract][Full Text] [Related]
7. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
8. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
[TBL] [Abstract][Full Text] [Related]
9. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
10. Expression of alpha1 adrenoceptor subtypes mRNA in hepatic tissues of cirrhotic patients with portal hypertension.
Zhu J; Chen L; Leng X; Du R
Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):325-8. PubMed ID: 11832047
[TBL] [Abstract][Full Text] [Related]
11. [Nitric oxide in pathogenesis of cirrhotic portal hypertension in rats and its hemodynamic effects].
Zhang J; Zhou H
Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):317-9. PubMed ID: 11825400
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between polymorphism of TaqI of ET-1 gene and cirrhotic portal hypertension].
Lin JS; Cheng YQ; Liao JZ; Liang KH; Xiong P
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):463-6. PubMed ID: 12887757
[TBL] [Abstract][Full Text] [Related]
13. The role of vasoactive substances in hyperhemodynamics after orthotopic liver transplantation in cirrhotic rats.
Cao H; Wu Z; Zhang X; Zhang H; Chen Z; Kuang Y
Chin Med J (Engl); 2003 Mar; 116(3):405-9. PubMed ID: 12781047
[TBL] [Abstract][Full Text] [Related]
14. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
[TBL] [Abstract][Full Text] [Related]
15. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Chan CC; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415
[TBL] [Abstract][Full Text] [Related]
16. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
[TBL] [Abstract][Full Text] [Related]
17. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
Geerts AM; De Vriese AS; Vanheule E; Van Vlierberghe H; Mortier S; Cheung KJ; Demetter P; Lameire N; De Vos M; Colle I
Liver Int; 2006 Sep; 26(7):889-98. PubMed ID: 16911473
[TBL] [Abstract][Full Text] [Related]
18. Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis.
Nagasue N; Dhar DK; Yamanoi A; Emi Y; Udagawa J; Yamamoto A; Tachibana M; Kubota H; Kohno H; Harada T
Hepatology; 2000 May; 31(5):1107-14. PubMed ID: 10796886
[TBL] [Abstract][Full Text] [Related]
19. [The role of hepatic sinusoid capillarization during the formation of portal hypertension in fibrotic rats induced by dimethylnitrosamine].
Lu X; Liu P; Xu GF; Liu CH; Li FH; Liu C
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):595-8. PubMed ID: 14572335
[TBL] [Abstract][Full Text] [Related]
20. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension.
Takashimizu S; Kojima S; Nishizaki Y; Kagawa T; Shiraishi K; Mine T; Watanabe N
Tokai J Exp Clin Med; 2011 Jul; 36(2):37-43. PubMed ID: 21769771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
